Menu
GeneBe

PUF60

poly(U) binding splicing factor 60, the group of RNA binding motif containing|Spliceosomal A complex

Basic information

Region (hg38): 8:143816343-143830709

Links

ENSG00000179950NCBI:22827OMIM:604819HGNC:17042Uniprot:Q9UHX1AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • 8q24.3 microdeletion syndrome (Strong), mode of inheritance: AD
  • 8q24.3 microdeletion syndrome (Strong), mode of inheritance: AD
  • 8q24.3 microdeletion syndrome (Definitive), mode of inheritance: AD
  • syndromic intellectual disability (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Verheij syndromeADCardiovascularThe condition can involve congenital cardiac anomalies, and awareness may allow early managementCardiovascular; Craniofacial; Musculoskeletal; Ophthalmologic; Renal19464398; 24140112
There is evidence that the condition may result from a deletion of multiple genes including PUF60 as well as heterozygous pathogenic variants in PUF60 alone

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PUF60 gene.

  • not provided (89 variants)
  • 8q24.3 microdeletion syndrome (60 variants)
  • Inborn genetic diseases (16 variants)
  • not specified (2 variants)
  • PUF60-related condition (2 variants)
  • CHARGE association (1 variants)
  • Intellectual disability-cardiac anomalies-short stature-joint laxity syndrome (1 variants)
  • See cases (1 variants)
  • Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PUF60 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
16
clinvar
2
clinvar
18
missense
13
clinvar
36
clinvar
3
clinvar
1
clinvar
53
nonsense
8
clinvar
4
clinvar
12
start loss
0
frameshift
21
clinvar
13
clinvar
34
inframe indel
1
clinvar
3
clinvar
2
clinvar
6
splice donor/acceptor (+/-2bp)
3
clinvar
6
clinvar
2
clinvar
11
splice region
4
2
6
non coding
1
clinvar
2
clinvar
2
clinvar
5
Total 32 37 42 23 5

Variants in PUF60

This is a list of pathogenic ClinVar variants found in the PUF60 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
8-143816521-C-G Uncertain significance (Dec 08, 2022)2504989
8-143816524-G-A Inborn genetic diseases Uncertain significance (Dec 12, 2023)3149778
8-143816525-CAG-C Neurodevelopmental abnormality • PUF60-related disorder Uncertain significance (Feb 16, 2024)984580
8-143816542-T-C Intellectual disability-cardiac anomalies-short stature-joint laxity syndrome Pathogenic (-)2690939
8-143816575-A-T 8q24.3 microdeletion syndrome Likely pathogenic (Jul 01, 2023)2663765
8-143816594-A-T Uncertain significance (Nov 10, 2022)2502036
8-143816612-GGATGGCCTTAT-G Likely pathogenic (Jan 19, 2017)425568
8-143816630-C-G PUF60-related disorder Uncertain significance (Jun 14, 2023)2637314
8-143816630-C-CA 8q24.3 microdeletion syndrome Pathogenic (Dec 10, 2018)973253
8-143816631-A-G Benign/Likely benign (Mar 01, 2023)774250
8-143816635-G-A Inborn genetic diseases Likely benign (Jan 23, 2023)2455583
8-143816641-GA-G 8q24.3 microdeletion syndrome Likely pathogenic (Jun 26, 2018)666578
8-143816646-C-T PUF60-related disorder Likely benign (Jun 29, 2020)3036484
8-143816650-A-C 8q24.3 microdeletion syndrome Likely pathogenic (Jan 01, 2022)1527938
8-143816705-AGAT-A Inborn genetic diseases Conflicting classifications of pathogenicity (Dec 04, 2019)421110
8-143816711-T-C 8q24.3 microdeletion syndrome • Inborn genetic diseases Uncertain significance (Jun 18, 2021)1031058
8-143816728-C-T Likely pathogenic (Jan 19, 2017)425566
8-143816729-C-T 8q24.3 microdeletion syndrome Pathogenic/Likely pathogenic (Sep 23, 2022)986397
8-143816741-A-G 8q24.3 microdeletion syndrome Likely pathogenic (-)1334132
8-143816741-ACTC-A Inborn genetic diseases Uncertain significance (Mar 13, 2024)3149777
8-143816752-A-G 8q24.3 microdeletion syndrome Pathogenic (Dec 21, 2018)599208
8-143816790-C-T PUF60-related disorder Likely benign (Dec 21, 2022)3030123
8-143816801-G-A PUF60-related disorder Uncertain significance (Feb 06, 2024)3057106
8-143816801-G-C Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities Likely pathogenic (-)997952
8-143816816-T-C 8q24.3 microdeletion syndrome Uncertain significance (Oct 18, 2022)2435303

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PUF60protein_codingprotein_codingENST00000526683 1213516
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9970.00323124283051242880.0000201
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense4.441113420.3250.00002093605
Missense in Polyphen863.9550.12509686
Synonymous-2.281801451.240.00001031145
Loss of Function4.33225.70.07780.00000118293

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002910.0000291
Ashkenazi Jewish0.000.00
East Asian0.0001110.000111
Finnish0.000.00
European (Non-Finnish)0.00002750.0000178
Middle Eastern0.0001110.000111
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: DNA- and RNA-binding protein, involved in several nuclear processes such as pre-mRNA splicing, apoptosis and transcription regulation. In association with FUBP1 regulates MYC transcription at the P2 promoter through the core-TFIIH basal transcription factor. Acts as a transcriptional repressor through the core-TFIIH basal transcription factor. Represses FUBP1-induced transcriptional activation but not basal transcription. Decreases ERCC3 helicase activity. Does not repress TFIIH-mediated transcription in xeroderma pigmentosum complementation group B (XPB) cells. Is also involved in pre-mRNA splicing. Promotes splicing of an intron with weak 3'-splice site and pyrimidine tract in a cooperative manner with U2AF2. Involved in apoptosis induction when overexpressed in HeLa cells. Isoform 6 failed to repress MYC transcription and inhibited FIR-induced apoptosis in colorectal cancer. Isoform 6 may contribute to tumor progression by enabling increased MYC expression and greater resistance to apoptosis in tumors than in normal cells. Modulates alternative splicing of several mRNAs. Binds to relaxed DNA of active promoter regions. Binds to the pyrimidine tract and 3'-splice site regions of pre-mRNA; binding is enhanced in presence of U2AF2. Binds to Y5 RNA in association with TROVE2. Binds to poly(U) RNA. {ECO:0000269|PubMed:10606266, ECO:0000269|PubMed:10882074, ECO:0000269|PubMed:11239393, ECO:0000269|PubMed:16452196, ECO:0000269|PubMed:16628215, ECO:0000269|PubMed:17579712}.;
Disease
DISEASE: Verheij syndrome (VRJS) [MIM:615583]: A syndrome characterized by growth retardation, delayed psychomotor development, dysmorphic facial features, and skeletal, mainly vertebral, abnormalities. Additional variable features may include coloboma, renal defects, and cardiac defects. {ECO:0000269|PubMed:24140112}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Spliceosome - Homo sapiens (human);Metabolism of RNA;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA (Consensus)

Recessive Scores

pRec
0.142

Intolerance Scores

loftool
0.357
rvis_EVS
-0.71
rvis_percentile_EVS
14.4

Haploinsufficiency Scores

pHI
0.247
hipred
Y
hipred_score
0.775
ghis
0.536

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
H
gene_indispensability_pred
E
gene_indispensability_score
0.970

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Puf60
Phenotype

Gene ontology

Biological process
mRNA splicing, via spliceosome;apoptotic process
Cellular component
nucleoplasm;cell junction
Molecular function
DNA binding;RNA binding;protein binding;identical protein binding;cadherin binding